Volitionrx limited announces successful detection of nucleosomes in cats

Clinical paper published in bmc veterinary research henderson, nev. , may 19, 2025 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, today announces the publication of "evaluation of plasma nucleosome concentrations and the effect of pre-analytical variables in healthy cats" in bmc veterinary research.
VNRX Ratings Summary
VNRX Quant Ranking